GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs

BACKGROUND: A meta-analysis is presented of cardiovascular outcome trials (CVOTs) comparing glucagon-like peptide-1 receptor agonists (GLP-1RA) versus placebo on cardiorenal outcomes in patients with type 2 diabetes mellitus (T2DM). METHODS: We did an electronic search up to June 30, 2021, for eligi...

Descripción completa

Detalles Bibliográficos
Autores principales: Giugliano, Dario, Scappaticcio, Lorenzo, Longo, Miriam, Caruso, Paola, Maiorino, Maria Ida, Bellastella, Giuseppe, Ceriello, Antonio, Chiodini, Paolo, Esposito, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442438/
https://www.ncbi.nlm.nih.gov/pubmed/34526024
http://dx.doi.org/10.1186/s12933-021-01366-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442438/
https://www.ncbi.nlm.nih.gov/pubmed/34526024
http://dx.doi.org/10.1186/s12933-021-01366-8

Ejemplares similares